Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalie Grover

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Clinical Case Reports|March 14, 2022
Epstein-Barr virus mucocutaneous ulcer followed by Hodgkin lymphoma in multiple myeloma patientMoriah Forster, Yuri Fedoriw, Sascha Tuchman, et al.
Leukemia & Lymphoma|January 6, 2018
Bortezomib in combination with dose-adjusted EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin) induces long-term survival in patients with plasmablastic lymphoma: a retrospective analysisChristopher Dittus, Natalie Grover, Steven Ellsworth, et al.
International Journal of Molecular Sciences|May 13, 2023
Thrombotic Events Are Unusual Toxicities of Chimeric Antigen Receptor T-Cell TherapiesChristopher Schorr, Jorge Forindez, Manuel Espinoza-Gutarra, et al.
Leukemia & Lymphoma|September 16, 2020
Identification of high-risk monomorphic post-transplant lymphoproliferative disorder following solid organ transplantationTimothy J Voorhees, Kavya K Kannan, Jonathan Galeotti, et al.
Haematologica|November 27, 2025
Comparative effectiveness of immunotherapy alone or with chemotherapy as first-line treatment for marginal zone lymphomaAdam J Olszewski, Thomas A Ollila, Dai Chihara, et al.
Leukemia & Lymphoma|June 19, 2018
Deferred treatment is a safe and viable option for selected patients with mantle cell lymphomaOscar Calzada, Jeffrey M Switchenko, Joseph J Maly, et al.
Blood Advances|October 19, 2021
Pretherapy metabolic tumor volume is associated with response to CD30 CAR T cells in Hodgkin lymphomaTimothy J Voorhees, Beibo Zhao, Jorge Oldan, et al.
Medrxiv : the Preprint Server for Health Sciences|July 23, 2024
Infectious Complications Following CD30 Chimeric Antigen Receptor T-Cell Therapy in AdultsFelicia Cao, Yueling Xiu, Michael Mohnasky, et al.
Open Forum Infectious Diseases|September 22, 2025
Infectious Complications Following CD30 Chimeric Antigen Receptor T-cell Therapy in AdultsFelicia Cao, Yueling Xiu, Michael Mohnasky, et al.
Transplantation and Cellular Therapy|January 1, 2026
ASTCT Clinical Practice Recommendations for Transplantation in Classical Hodgkin LymphomaSairah Ahmed, Ambuj Kumar, Paul Carpenter, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Clinical Case Reports|March 14, 2022
Epstein-Barr virus mucocutaneous ulcer followed by Hodgkin lymphoma in multiple myeloma patientMoriah Forster, Yuri Fedoriw, Sascha Tuchman, et al.
Leukemia & Lymphoma|January 6, 2018
Bortezomib in combination with dose-adjusted EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin) induces long-term survival in patients with plasmablastic lymphoma: a retrospective analysisChristopher Dittus, Natalie Grover, Steven Ellsworth, et al.
International Journal of Molecular Sciences|May 13, 2023
Thrombotic Events Are Unusual Toxicities of Chimeric Antigen Receptor T-Cell TherapiesChristopher Schorr, Jorge Forindez, Manuel Espinoza-Gutarra, et al.
Leukemia & Lymphoma|September 16, 2020
Identification of high-risk monomorphic post-transplant lymphoproliferative disorder following solid organ transplantationTimothy J Voorhees, Kavya K Kannan, Jonathan Galeotti, et al.
Haematologica|November 27, 2025
Comparative effectiveness of immunotherapy alone or with chemotherapy as first-line treatment for marginal zone lymphomaAdam J Olszewski, Thomas A Ollila, Dai Chihara, et al.
Leukemia & Lymphoma|June 19, 2018
Deferred treatment is a safe and viable option for selected patients with mantle cell lymphomaOscar Calzada, Jeffrey M Switchenko, Joseph J Maly, et al.
Blood Advances|October 19, 2021
Pretherapy metabolic tumor volume is associated with response to CD30 CAR T cells in Hodgkin lymphomaTimothy J Voorhees, Beibo Zhao, Jorge Oldan, et al.
Medrxiv : the Preprint Server for Health Sciences|July 23, 2024
Infectious Complications Following CD30 Chimeric Antigen Receptor T-Cell Therapy in AdultsFelicia Cao, Yueling Xiu, Michael Mohnasky, et al.
Open Forum Infectious Diseases|September 22, 2025
Infectious Complications Following CD30 Chimeric Antigen Receptor T-cell Therapy in AdultsFelicia Cao, Yueling Xiu, Michael Mohnasky, et al.
Transplantation and Cellular Therapy|January 1, 2026
ASTCT Clinical Practice Recommendations for Transplantation in Classical Hodgkin LymphomaSairah Ahmed, Ambuj Kumar, Paul Carpenter, et al.
Pageof 2